- Home
- MTLS vs RVNC Comparison
MTLS vs RVNC Comparison
Compare MTLS & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTLS
- RVNC
- Stock Information
- Founded
- MTLS 1990
- RVNC 1999
- Country
- MTLS Belgium
- RVNC United States
- Employees
- MTLS N/A
- RVNC N/A
- Industry
- MTLS Computer Software: Prepackaged Software
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- MTLS Technology
- RVNC Health Care
- Exchange
- MTLS Nasdaq
- RVNC Nasdaq
- Market Cap
- MTLS 321.3M
- RVNC 546.4M
- IPO Year
- MTLS 2014
- RVNC 2014
- Fundamental
- Price
- MTLS $5.19
- RVNC $5.29
- Analyst Decision
- MTLS Buy
- RVNC Buy
- Analyst Count
- MTLS 1
- RVNC 10
- Target Price
- MTLS $9.50
- RVNC $10.86
- AVG Volume (30 Days)
- MTLS 75.5K
- RVNC 1.3M
- Earning Date
- MTLS 10-24-2024
- RVNC 11-06-2024
- Dividend Yield
- MTLS N/A
- RVNC N/A
- EPS Growth
- MTLS N/A
- RVNC N/A
- EPS
- MTLS 0.20
- RVNC N/A
- Revenue
- MTLS $276,287,367.00
- RVNC $251,178,000.00
- Revenue This Year
- MTLS $6.94
- RVNC $20.36
- Revenue Next Year
- MTLS $9.37
- RVNC $31.66
- P/E Ratio
- MTLS $26.05
- RVNC N/A
- Revenue Growth
- MTLS 2.45
- RVNC 40.23
- 52 Week Low
- MTLS $4.70
- RVNC $2.30
- 52 Week High
- MTLS $6.93
- RVNC $9.75
- Technical
- Relative Strength Index (RSI)
- MTLS 51.23
- RVNC 44.50
- Support Level
- MTLS $5.02
- RVNC $5.10
- Resistance Level
- MTLS $5.44
- RVNC $5.43
- Average True Range (ATR)
- MTLS 0.14
- RVNC 0.17
- MACD
- MTLS 0.02
- RVNC 0.02
- Stochastic Oscillator
- MTLS 48.94
- RVNC 66.67
About MTLS Materialise NV
Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, Poland, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.